CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $517.71 ($4,918,273)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $511.97 ($4,863,730)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $518.39 ($4,924,666)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $521.02 ($4,949,717)
- 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $523.14 ($4,342,079)
- 144 Insider Sale of Securities
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $526.96 ($5,006,104)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $515.60 ($4,898,221)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $506.59 ($4,812,568)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $498.91 ($4,739,664)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $504.24 ($4,790,316)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $515.03 ($4,892,748)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $522.87 ($4,967,292)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $530.11 ($5,036,073)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $531.38 ($5,048,137)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $525.36 ($4,990,873)
- 4 Planned sale EVP & GENERAL COUNSEL sold 8,300 shares at an average $517.05 ($4,291,512)
- 4 Planned sale Chairperson & CEO sold 9,500 shares at an average $518.74 ($4,927,985)
Page 5 of 222 · 4,426 filings